An Antibody That Fights Tumors Three Ways Just Got a U.S. Patent Nod
Purple Biotech's CAPTN-3 platform uses a modular design: swap out the tumor-targeting piece and the rest of the antibody stays put. The U.S. patent office says that architecture is patentable. The patent isn't issued yet.